Smart Implantable Pumps Market Size to Surpass US$ 3.77 Billion by 2031 – Growth Plus Reports

Newark, New Castle, USA, June 08, 2023 (GLOBE NEWSWIRE) — The market analysis of the global smart implantable pumps market was conducted by Growth Plus Reports in 2022 and is valued at US$ 2.14 billion. The market is expected to hit a revenue CAGR of 7.3% to reach US$ 3.77 billion by 2031.

Analysis of the global market for smart implantable pumps indicates that during the forecast period, revenue share is likely to increase significantly. 

The Smart Implantable Pumps market represents a transformative approach to drug delivery, revolutionizing the healthcare industry. These innovative medical devices leverage artificial intelligence and advanced technology to provide precise and personalized administration of medications directly into the patient’s bloodstream. With real-time monitoring, adaptive drug delivery, and enhanced safety features, Smart Implantable Pumps offer improved treatment outcomes, patient comfort, and the potential to manage a wide range of chronic conditions effectively.

Request a Free Sample Copy of the Research Report: https://www.growthplusreports.com/inquiry/request-sample/smart-implantable-pumps-market/8986

                               Smart Implantable Pumps Market Scope

The Smart Implantable Pumps market is being driven by the increasing prevalence of chronic diseases, advancements in medical technology and artificial intelligence, growing demand for patient-centric care, the rise in the geriatric population, and favorable regulatory environments. These pumps offer precise and controlled drug administration, personalized treatment through real-time monitoring and adaptive drug delivery, and improved patient experience. North America currently accounts for the largest market share, followed by Europe and Asia Pacific, while companies are focusing on collaborations, product launches, and research and development activities to stay competitive in this rapidly expanding market.

However, because of their cutting-edge technology, compactness, and customization choices, smart implanted pumps are pricey. The high price of these products could make them unaffordable and inaccessible to some patient populations, which would limit the market growth for smart implanted pumps.

Recent Development in the Smart Implantable Pumps Market: 

• In January 2023, the signing of a legally binding business merger agreement between Nocturne Acquisition Corporation and Cognos Therapeutics, Inc. was announced. According to the terms of the all-stock agreement, Cognos investors will receive a total of $120 million worth of Nocturne common stock (subject to certain modifications), with each share being priced at $10.30 for the transaction.

Competitive Landscape

A list of the prominent players operating in the global market for smart implantable pumps includes: 

• Baxter International Inc.
• Tricumed Medizintechnik GmbH
• Flowonix Meidcal Inc.
• Cognos Therapeutics, Inc.
• Intarcia Therapeutics, Inc. 

Request for Customization – https://www.growthplusreports.com/inquiry/customization/smart-implantable-pumps-market/8986

Market Segmentation: 

Based on type, the global smart implantable pumps market is segmented into perfusion pumps and micro pumps. 

The perfusion pumps segment accounted for the largest revenue share of the smart implantable pumps market, with approximately 58% in 2022. 

Based on application, the global smart implantable pumps market pain, spasticity, cardiovascular, and others. 

North America has a high prevalence of chronic diseases, including cancer, cardiovascular diseases, and chronic pain.

Table of Content

1. INTRODUCTION
   1. Market Ecosystem
   2. Timeline Under Consideration
      1. Historical Years – 2021
      2. Base Year – 2022
      3. Forecast Years – 2023 to 2031
   3. Currency Used in the Report
2. RESEARCH METHODOLOGY 
   1. Research Approach
   2. Data Collection Methodology
   3. Data Sources
      1. Secondary Sources 
      2. Primary Sources
   4. Market Estimation Approach
      1. Bottom Up
      2. Top Down 
   5. Market Forecasting Model
   6. Limitations and Assumptions
3. PREMIUM INSIGHTS
   1. Current Market Trends (COVID-19 Perspective)
   2. Key Players & Competitive Positioning (2022) 
   3. Regulatory Landscape
   4. Reimbursement Sicario 
4. MARKET DYNAMICS
   1. Drivers
   2. Restraints/Challenges
   3. Opportunities
5. GLOBAL SMART IMPLANTABLE PUMPS MARKET- ANALYSIS & FORECAST, BY TYPE
   1. Perfusion Pumps
   2. Micro Pumps
6. GLOBAL SMART IMPLANTABLE PUMPS MARKET- ANALYSIS & FORECAST, BY APPLICATION
   1. Pain
   2. Spasticity
   3. Cardiovascular
   4. Others

SMART IMPLANTABLE PUMPS MARKET TOC

Buy this Premium Research Report: https://www.growthplusreports.com/checkout-8986

VALUE PROPOSITIONS RELATED TO THE REPORT:

• Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
• Comprehensive quantitative and qualitative insights at segment and sub-segment level
• Covid 19 impact trends and perspective
• Granular insights at global/regional/country level
• Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
• Blanket coverage on competitive landscape
• Winning imperatives
• Exhaustive coverage on ‘Strategic Developments’ registered by leading players of the market.

CUSTOMIZATION OPTIONS:

• Distributor Landscape Assessment
• Pricing Intelligence
• Customer Base Assessment
• Investment & Initiatives Analysis
• ‘Business Profile’ of Key Players

Schedule a call with our analyst: https://appoint.ly/s/salesZ3Jvd3RocGx1c3JlcG9ydHMuY29t/introduction

Visit our report store at – https://www.growthplusreports.com/report-store

Browse more latest healthcare reports:

SV2A Ligands Market by Drug (Brivaracetam, Levetiracetam, Others), Types of Seizures (Myoclonic seizures, Partial onset seizures, Primary generalized tonic-colonic seizures, Ohers) Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) – Global Outlook & Forecast 2023-2031

Seizure Monitoring Market by Type (Wearable Sensors, Bed Monitors, Video Systems), End User (Hospitals, Homecare Settings, and Others) – Global Outlook and Forecast 2023-2031

Amorphous Hydrogel Dressings Market by Application (Burns, Pressure Ulcers), End User (Hospitals, Ambulatory Surgical Centers), Distribution Channel (Retail Pharmacies, Online Pharmacies)– Global Outlook & Forecast 2023-2031

Prurigo Nodularis Treatment Market by Product Type (Antihistamines, Corticosteroids), Distribution Channel (Retail Pharmacies, Hospital Pharmacies) – Global Outlook & Forecast 2023-2031

Eosinophilia-Myalgia Syndrome Market by Medication (Muscle Relaxants, Pain Relievers, Diuretics), Route of Administration (Oral, Topical, Parenteral), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Global Outlook & Forecast 2023-2031

About Us:

Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as “Most Innovative Healthcare Market Research Company in 2020”.